Table 1.
Top 10 countries in the world for IBD funding (2013–2017)
| United States | United Kingdom | Belgium | Canada | Switzerland | Sweden | Norway | Australia | Japan | Poland | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Funding (millions of CAD) | $2,227 | $215.3 | $177.5 | $119.5 | $44.80 | $32.24 | $31.82 | $28.71 | $24.78 | $15.83 |
| % of World Funding | 75.9% | 7.3% | 6.1% | 4.0% | 1.5% | 1.1% | 1.1% | 1.0% | 0.8% | 0.5% |
| IBD Prevalence per 100,000 (Study period)1 | 533.0 (2011)2 | 373.0 (2002)3 | n/a | 725.0 (2018)4 | 205.7 (2005)5 | 540.0 (2010)6 | 767.0 (1990–93)7 | 401.8 (2010–11)8 | 75.9 (2003–05)9 | n/a |
| 2017 Estimated Number of Prevalent Cases of IBD* | 1,736,083 | 246,263 | n/a | 270,000 | 17,414 | 54,365 | 40,514 | 98,838 | 96,230 | n/a |
| Funding per capita of prevalent IBD patients | $1282.77 | $874.27 | n/a | $426.42 | $2,572.64 | $593.03 | $785.41 | $290.48 | $257.51 | n/a |
*Based on country population according to: The World Bank.10